Irish drug trial technology firm Teckro wins $25 million injection - (London South East via NewsPoints Desk)

  • Teckro has received $25 million in funding from investors as it plans for a public listing, as reported London South East Thursday.

  • The firm plans to use the proceeds to expand internationally and develop its machine-learning based digital platform.

  • CEO Gary Hughes said Teckro's platform is currently used by more than 10 000 healthcare practitioners, while its commercial partners include large drugmakers as well as smaller biotech firms.

  • "This time our ambition is to go all the way," Hughes remarked, continuing "an [initial public offering] is potentially out there. We don't have a specific time frame in mind, other than we're thinking long term for Teckro."

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.